Note: Ingredients listed on restricted chemical lists
EC/CAS
68359-37-5
Name of the chemical
Cyfluthrin (ISO); α-Cyan-4-fluor-3-phenoxybenzyl-3-(2,2-dichlorvinyl)-2,2-dimethylcyclopropancarboxylat (2022/692)
Concentration
N/A
EC/CAS
14808-60-7
Name of the chemical
Silica, crystalline
Concentration
N/A
General Information
Revision date
2001-11-07
Product name
BAYER ADVANCED LAWN Fire Ant Killer Ready-To-Use Dust
Product Synonyms
Cyfluthrin
Chemical name
Pyrethroid Insecticide
1.2.1 Relevant identified uses
Consumer Insecticide -------------------------------------------------------------------------------
Icons in SDS
Section 2
SECTION 2: Hazards identification
EMERGENCY OVERVIEW * CAUTION! Color White; Form Solid; Powder; Odor Musty * talc; Harmful if inhaled; Causes eye irritation; Harmful if * * swallowed. * *****************************************************************
Principle Routes of Exposure
Inhalation; Skin Contact; Eye Contact HUMAN EFFECTS AND SYMPTOMS OF OVEREXPOSURE: ACUTE EFFECTS OF EXPOSURE.....: Exposure during the labeled use of this product is expected to be minimal. Consumers should refer to the packaging label for proper handling procedures. Sufficient exposure to cyfluthrin, the active ingredient in this product, may cause eye or skin irritation characterized by redness or itching. In addition, sufficient exposure to cyfluthrin may produce paraesthesia (a tingling or burning sensation on the surface of the skin. This is a frequently reported symptom associated with sufficient dermal exposure to alpha-cyano (Type II) synthetic pyrethroids and normally subsides without treatment within 24 hours. The onset of these symptoms usually occurs 2-12 hours after exposure. Mucous membrane irritation involving the nose, throat and upper respiratory tract may occur from inhalation of aerosols containing cyfluthrin. Based on EPA Toxicity Category criteria, this material is mildly toxic by the oral and dermal See Animal Toxicity Section for additional information.
Potential chronic health
OF EXPOSURE... Based on animal studies, no adverse effects or symptoms would be expected from chronic exposure to the active ingredient in this product during normal use. This product may contain up to approximately 0.3% total crystalline silica. However, the amount of respirable crystalline silica is expected to be significantly lower based on data provided by the raw material manufacturer. Excessive long-term exposure to respirable crystalline silica may cause silicosis, a form of progressive pulmonary fibrosis. Severe and permanent lung damage may result. CARCINOGENICITY...............: This product is not listed as a carcinogen by NTP or IARC or regulated as a carcinogen by
